College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, 46241, South Korea.
Department of Pharmacy, Kangwon National University, Chuncheon-si, Gangwon-do, 24341, South Korea.
Arch Pharm Res. 2021 Jun;44(6):574-587. doi: 10.1007/s12272-021-01338-2. Epub 2021 Jun 24.
The liver is a vital organ responsible for various physiological functions, such as metabolism, immune response, digestion, and detoxification. Crosstalk between hepatocytes, hepatic macrophages, and hepatic stellate cells is critical for liver pathology. Exosomes are small extracellular vesicles (50-150 nm) that play an important role in cell-cell or organ-organ communication as they transfer their cargo, such as protein, DNA, and RNA to recipient cells or distant organs. In various liver diseases, the number of liver cell-derived exosomes is increased and the exosomal microRNA (miRNA) profile is altered. Early studies investigated the value of circulating exosomal miRNAs as biomarkers. Several exosomal miRNAs showed excellent diagnostic values, suggesting their potential as diagnostic biomarkers in liver diseases. Exosomal miRNAs have emerged as critical regulators of liver pathology because they control the expression of multiple genes in recipient cells. In this review, we discuss the biology of exosomes and summarize the recent findings of exosome-mediated intercellular and organ-to-organ communication during liver pathology. As there are many review articles dealing with exosomal miRNAs in liver cancer, we focused on non-malignant liver diseases. The therapeutic potential of exosomal miRNAs in liver pathology is also highlighted.
肝脏是一个重要的器官,负责多种生理功能,如代谢、免疫反应、消化和解毒。肝细胞、肝巨噬细胞和肝星状细胞之间的串扰对于肝脏病理学至关重要。外泌体是一种小的细胞外囊泡(50-150nm),它们在细胞间或器官间的通讯中发挥着重要作用,因为它们可以将其货物(如蛋白质、DNA 和 RNA)转移到受体细胞或远处的器官。在各种肝脏疾病中,肝细胞来源的外泌体数量增加,外泌体 microRNA(miRNA)谱发生改变。早期研究探讨了循环外泌体 miRNA 作为生物标志物的价值。一些外泌体 miRNA 显示出优异的诊断价值,表明它们在肝脏疾病中具有作为诊断生物标志物的潜力。外泌体 miRNA 已成为肝脏病理学的关键调节因子,因为它们可以控制受体细胞中多个基因的表达。在这篇综述中,我们讨论了外泌体的生物学,并总结了最近关于外泌体介导的肝脏病理学中细胞间和器官间通讯的发现。由于有许多关于外泌体 miRNA 在肝癌中的综述文章,我们重点介绍了非恶性肝脏疾病。还强调了外泌体 miRNA 在肝脏病理学中的治疗潜力。